Windsor Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Windsor Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,663	Closed	-$93K	–	399
2015 Q3	$93K	Buy	+1,663	New	+$108K	0.05%	129
2014 Q1	–	Sell	-2,304	Closed	-$92K	–	274
2013 Q4	$92K	Buy	2,304 +7	+0.3%	+$276	0.05%	124
2013 Q3	$87K	Buy	2,297 +8	+0.3%	+$312	0.05%	129
2013 Q2	$90K	Buy	+2,289	New	+$89.1K	0.05%	113

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Windsor Capital Management's TEVA Position: Q4 2015 in Review

Windsor Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 1,663 shares — an estimated $93K sold.

Windsor Capital Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $93K in Q3 2015. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Windsor Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Windsor Capital Management sold 1,663 Teva Pharmaceuticals shares in Q4 2015, an estimated $93K.
Windsor Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Windsor Capital Management's Teva Pharmaceuticals position peaked at $93K in Q3 2015.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Windsor Capital Management's 13F filing for Q4 2015, filed 1 Feb 2016.